APA

Kaczmarek E., Saint-Martin C., Pierga J., Brain E., Rouzier R., Savignoni A., Mouret-Fourme E., Dieras V., Piot I., Dubot C., Carton M. & Lerebours F. (20200320). Long-term survival in HER2-positive metastatic breast cancer treated with first-line trastuzumab: results from the french real-life curie database. : Breast cancer research and treatment.

Chicago

Kaczmarek E, Saint-Martin C, Pierga J-Y, Brain E, Rouzier R, Savignoni A, Mouret-Fourme E, Dieras V, Piot I, Dubot C, Carton M and Lerebours F. 20200320. Long-term survival in HER2-positive metastatic breast cancer treated with first-line trastuzumab: results from the french real-life curie database. : Breast cancer research and treatment.

Harvard

Kaczmarek E., Saint-Martin C., Pierga J., Brain E., Rouzier R., Savignoni A., Mouret-Fourme E., Dieras V., Piot I., Dubot C., Carton M. and Lerebours F. (20200320). Long-term survival in HER2-positive metastatic breast cancer treated with first-line trastuzumab: results from the french real-life curie database. : Breast cancer research and treatment.

MLA

Kaczmarek E, Saint-Martin C, Pierga J-Y, Brain E, Rouzier R, Savignoni A, Mouret-Fourme E, Dieras V, Piot I, Dubot C, Carton M and Lerebours F. Long-term survival in HER2-positive metastatic breast cancer treated with first-line trastuzumab: results from the french real-life curie database. : Breast cancer research and treatment. 20200320.